Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Karthikeyan Subbarayan
Observed names:
K. Subbarayan,
Subbarayan, Karthikeyan
Institutions:
Medizinische Hochschule Brandenburg Theodor Fontane,
Universitätsklinikum Brandenburg an der Havel,
Martin Luther University Halle-Wittenberg
Observed institutions:
Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK),
Medizinische Hochschule Brandenburg Theodor Fontane,
Universitätsklinikum Brandenburg an der Havel,
Martin Luther University Halle-Wittenberg
ORCID:
0000-0002-5140-0253
Observed ORCID:
0000-0002-5140-0253
OpenAlex ID:
A5021228969
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
2019
·
Michael Friedrich
, Simon Jasinski-Bergner
, et al.
·
Cancer Immunology Immunotherapy
·
72
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma
2020
·
Maria-Filothei Lazaridou
, Chiara Massa
, et al.
·
Journal of Clinical Medicine
·
27
PDF
Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells
2017
·
Karthikeyan Subbarayan
, Sandra Leisz
, et al.
·
OncoImmunology
·
25
PDF
Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients’ Outcome
2018
·
Karthikeyan Subbarayan
, Barbara Seliger
·
Current Cancer Drug Targets
·
21
Influence of oxygen deficiency and the role of specific amino acids in cryopreservation of garlic shoot tips
2015
·
Karthikeyan Subbarayan
, Hardy Rolletschek
, et al.
·
BMC Biotechnology
·
19
PDF
Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma
2023
·
Helene Schäfer
, Karthikeyan Subbarayan
, et al.
·
Journal of Translational Medicine
·
15
PDF
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues
2020
·
Karthikeyan Subbarayan
, Kamatchi Ulagappan
, et al.
·
Current Cancer Drug Targets
·
11
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
2022
·
Christoforos K. Vaxevanis
, Marcus Bauer
, et al.
·
OncoImmunology
·
10
Identification of a novel miR‐21‐3p/TGF‐β signaling‐driven immune escape via the MHC class I/biglycan axis in tumor cells
2021
·
Karthikeyan Subbarayan
, Chiara Massa
, et al.
·
Clinical and Translational Medicine
·
10
PDF
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
2022
·
Karthikeyan Subbarayan
, Chiara Massa
, et al.
·
OncoImmunology
·
9
Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues
2021
·
Karthikeyan Subbarayan
, Kamatchi Ulagappan
, et al.
·
Frontiers in Immunology
·
9
PDF
Indole-3-Acetic Acid From Contaminant Fungus And Potential Application For Cell Cultures Of Alternanthera Sessilis
2010
·
Karthikeyan Subbarayan
, Nithya Varadharajan
, et al.
·
International Journal of Pharma and Bio Sciences
·
9
Experience in large-scale cryopreservation and links to applied research for safe storage of plant germplasm
2016
·
E.R.J. Keller
, M. Grübe
, et al.
·
Acta Horticulturae
·
8
Altered ACE2 and interferon landscape in the COVID-19 microenvironment correlate with the anti-PD-1 response in solid tumors
2024
·
Karthikeyan Subbarayan
, Ahmed Al-Samadi
, et al.
·
Cellular and Molecular Life Sciences
·
4
PDF
Link of TMPRSS2 expression with tumor immunogenicity and response to immune checkpoint inhibitors in cancers
2025
·
Karthikeyan Subbarayan
, Helena Bieber
, et al.
·
Journal of Translational Medicine
·
1
PDF
Development of a StIW111C-based bioresponsive pore-forming conjugate for permeabilizing the endosomal membrane
2025
·
Felipe A. Escalona-Rodriguez
, Javier La O-Bonet
, et al.
·
International Journal of Biological Macromolecules
·
1
868 PRELP-facilitated enhancement of MHC class I surface expression in B16F10 melanoma cells
2020
·
Helene Schäfer
, Karthikeyan Subbarayan
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Thidiazuron Induced Direct Regeneration from Leaf Explants of Scoparia dulcis L. – A Pharmaceutical Plant
2010
·
Karthikeyan Subbarayan
, K. Rajagopal
, et al.
·
Research Journal of Pharmacy and Technology
·
1
Enhanced tumor metastasis driven by the crosstalk between melanoma cells and tumor-associated macrophages: insights into the CXCL10/CXCR3-hnRNP C-MIF axis
2026
·
Yuan Wang
, Chiara Massa
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
FAP and PD-L1 Blockade Enhance T Cell Infiltration in ATC and Reveal a BTLA–Fibronectin Axis Linked to T Cell Activation and Exhaustion
2026
·
Mario Udinotti
, Dimitrios Kokoretsis
, et al.
PRELP-associated transcriptomic remodeling links alternative splicing and immune checkpoint blockade outcome in melanoma
2026
·
Karthikeyan Subbarayan
, Kamatchi Ulagappan
, et al.
·
Frontiers in Immunology
PDF
Alternative splicing changes associated with PRELP expression in melanoma
2026
·
Subbarayan, Karthikeyan
, Ulagappan, Kamatchi
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
PRELP-associated transcriptomic remodeling links alternative splicing and immune checkpoint blockade outcome in melanoma
2026
·
Subbarayan, Karthikeyan
, Ulagappan, Kamatchi
, et al.
·
Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt)
828 Improved growth properties and immune surveillance in K-RAS G12V-transformed cells through overexpression of biglycan
2020
·
Karthikeyan Subbarayan
, Sandra Leisz
, et al.
·
Journal for ImmunoTherapy of Cancer
Immune interaction map of human SARS-CoV-2 target proteins: implications for therapeutic avenues
2020
·
Karthikeyan Subbarayan
, Kamatchi Ulagappan
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
36
Citation count:
253
H-index:
9
I10-index:
9
Year
Topic
Type